SARS-CoV-2 variants and the global pandemic challenged by vaccine uptake during the emergence of the Delta variant: A national survey seeking vaccine hesitancy causesSARS-CoV-2 변종과 Delta 변종 출현 중 백신 섭취로 도전받는 세계적 대유행: 백신 주저성을 찾는 전국 조사Article Published on 2022-07-012022-09-11 Journal: Journal of infection and public health [Category] COVID19(2023년), SARS, 변종, [키워드] Analysis cause children collected conducted contribute COVID-19 COVID-19 infection COVID-19 vaccination COVID-19 vaccine COVID-19 vaccine hesitancy COVID-19 vaccine uptake cross-sectional survey Delta delta variant Effectiveness effort emergence family history females global pandemic Health healthcare worker herd immunity Hesitancy infected with COVID-19 information less Measures media men Ministry of Health misinformation much lower Multivariate analysis National NEWS P-value pandemic parent parental parents participant Participants Public receive reported SARS-CoV-2 SARS-CoV-2 Delta variant SARS-CoV-2 variant SARS-CoV-2 variants Saudi Arabia Saudi Arabia national survey. seeking social media social media platform social media platforms Sociodemographic Spread subject the vaccine vaccinate vaccination Vaccination Status Vaccine Vaccine hesitancy variable variant variants with COVID-19 women [DOI] 10.1016/j.jiph.2022.06.007 PMC 바로가기 [Article Type] Article
Associations of Clinical Factors and Blood Groups With the Severity of COVID-19 Infection in Makkah City, Saudi ArabiaObservational Study Published on 2022-06-212022-10-05 Journal: Frontiers in Cellular and Infection Microbiology [Category] 임상, [키워드] ABO ABO blood groups association Asthma Blood Blood Group chronic kidney diseases city clinical Clinical characteristics clinical factor confirmed COVID-19 case congestive heart failure correlation cough COVID-19 COVID-19 infection COVID-19 patient cross-sectional Deceased Diabetes Mellitus diagnosed disease distress distribution expected Factor Fever Frequency group higher infectivity Hospitalized hospitalized COVID-19 patient hypertension infected patient Infection Kingdom Makkah material medical record Ministry of Health Mortality no significant difference Patient patients PCR phenotype Pneumonia positive positive PCR Prevalence Respiratory failure retrieved Rh blood groups Risk factors risk of death Saudi Arabia severity of COVID-19 significantly increased significantly lower specialist Symptom Symptoms syndrome tested Western region with COVID-19 [DOI] 10.3389/fcimb.2022.870096 PMC 바로가기 [Article Type] Observational Study
Protection and Waning of Natural and Hybrid Immunity to SARS-CoV-2SARS-CoV-2에 대한 자연 및 하이브리드 면역의 보호 및 약화Article Published on 2022-06-092022-09-11 Journal: The New England Journal of Medicine [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adjusted B.1.617.2 BNT162b2 BNT162b2 vaccine confounding factor confounding factors coronavirus Coronavirus 2019 Course database dose elapsed hybrid Immunity infected with SARS-CoV-2 Infection less Ministry of Health natural natural immunity Poisson regression predominant protection provide provided rates of infection receipt recent Reinfection risk SARS-CoV-2 SARS-COV-2 infection second dose second dose of vaccine severe acute respiratory syndrome Coronavirus shown single dose uninfected vaccination Vaccine variant [DOI] 10.1056/NEJMoa2118946 PMC 바로가기 [Article Type] Article
Favipiravir, camostat, and ciclesonide combination therapy in patients with moderate COVID-19 pneumonia with/without oxygen therapy: An open-label, single-center phase 3 randomized clinical trialResearch article Published on 2022-06-032022-10-05 Journal: EClinicalMedicine [Category] 신약개발, 임상, 치료제, [키워드] 95% CI Admission Adverse AMED assigned calculated camostat Characteristics Ciclesonide clinical Clinical finding Clinical management Combination combination therapy comparable COVID-19 COVID-19 infection deaths decrease development discharge Effectiveness enrolled evaluated event Favipiravir finding funding group groups healthcare worker hospital discharge rate Hospital stay Hospitalization Hospitalized Japan Japanese lack less limitation median time Ministry of Health monotherapy no significant difference number Open-label oxygen participant Patient patients patients with moderate Phase 3 phase 3 study Pneumonia positive Primary outcome randomized clinical trial Randomized controlled trial Randomly Registered registry Research SARS-CoV-2 Severe COVID-19 Infection significantly higher significantly lower single-center statistically supported therapy Treatment vaccination Version Welfare [DOI] 10.1016/j.eclinm.2022.101484 [Article Type] Research article
Epidemiology of COVID-19 Among Indigenous Populations in BrazilObservational Study Published on 2022-06-012022-10-05 Journal: Journal of racial and ethnic health disparities [Category] COVID19(2023년), SARS, 임상, [키워드] adopted age Alto Brazil carried Community Complication Coronavirus infections COVID-19 death diagnosed with COVID-19 disease District dry cough ENhance Epidemics epidemiological situation Evolution female Fever headache Health of ethnic minorities Health of indigenous people. individual Infection Isolation lack Ministry of Health Most patient observation occurred Population populations reducing reported Rio Symptom [DOI] 10.1007/s40615-021-01035-2 PMC 바로가기 [Article Type] Observational Study
A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants멀티토프 SARS-CoV-2 백신은 Delta 및 Omicron 변이체에 대해 오래 지속되는 B 세포 및 T 세포 면역을 제공합니다Clinical Trial Published on 2022-05-162022-09-11 Journal: The Journal of Clinical Investigation [Category] COVID19(2023년), MERS, SARS, 변종, 임상, 진단, 치료기술, 치료법, [키워드] adverse event Antibody titers Asia B cell booster Breakthrough infection breakthrough infections center conducted conserved Control COVID-19 cross-reactive cytotoxic T lymphocyte Delta disease control dose elicited epitope Epitopes evaluated fatigue healthy helper T cell Heterologous human convalescent sera Immunity immunization immunogenicity Inc. injection site pain long-lasting lymphocyte membrane memory immunity Mild Ministry of Health Neutralizing antibodies Neutralizing antibody titer neutralizing antibody titers Neutralizing titer nucleocapsid omicron Omicron variants peptide peptides Phase I placebo-controlled Protein provide Randomized representing responsible safety profile sarbecovirus SARS-CoV-2 vaccine SARS-CoV-2 variant SARS-CoV-2 variants second dose Serious Adverse Event Serious Adverse Events subunit Subunit vaccine T cell Taiwan Trial trials Vaccine variant variants of SARS-CoV-2 virus-neutralizing antibody VOCs waning immunity Welfare were recorded [DOI] 10.1172/JCI157707 PMC 바로가기 [Article Type] Clinical Trial
A phase 2 randomized, double-blinded, placebo-controlled, multicenter trial evaluating the efficacy and safety of raloxifene for patients with mild to moderate COVID-19Research article Published on 2022-05-122022-10-05 Journal: EClinicalMedicine [Category] 신약개발, 임상, [키워드] Action acute respiratory syndrome adaptive clinical testing consumer coronavirus disease-2019 Coronavirus-2 COVID COVID-19 COVID-19 disease current decrease doses double-blinded Effect Efficacy and safety Emergency Endpoint enrolled Estrogen European Commission evaluate Evidence finding FIVE funding hospitalized patients immunomodulator indications instrument Italian Italy lack mechanical ventilation Medicine Mild Ministry of Health mitigate moderate Moderate COVID-19 modulate multicenter Multicenter trial Nasopharyngeal swab Occurrence participant Patient pharmacological Phase 2 study Placebo placebo-controlled placebo-controlled trial Prevent Primary outcome progression proinflammatory cytokines proportion raloxifene Randomized receive Registered Replication reported Safety safety profile SARS-CoV-2 Selective estrogen receptor modulator (SERM) Serious Adverse Events Seven supplemental oxygen Supplemental oxygen therapy Support supported therapeutic option treat Treatment Trial undetectable viral shedding [DOI] 10.1016/j.eclinm.2022.101450 [Article Type] Research article
Protection by a Fourth Dose of BNT162b2 against Omicron in Israel이스라엘의 오미크론에 대한 BNT162b2의 4차 투여에 의한 보호Article Published on 2022-05-052022-09-11 Journal: The New England Journal of Medicine [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adjusted age Analysis B.1.1.529 BNT162b2 BNT162b2 vaccine coronavirus coronavirus disease Coronavirus disease 2019 database dose doses eligible estimation Factor groups Infection Internal control Ministry of Health of BNT162b2 Older omicron predominant protection Rate receipt SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome Coronavirus severe coronavirus disease severe COVID-19 Sex short-lived study period Vaccine variant of SARS-CoV-2 waned [DOI] 10.1056/NEJMoa2201570 PMC 바로가기 [Article Type] Article
COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a light at the end of the tunnel?코로나19 예방접종과 SARS-CoV-2 오미크론(B.1.1.529) 변종: 터널 끝의 빛?Article Published on 2022-05-012022-09-11 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Admission analyzed B.1.1.529 concerning coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination database decrease diagnoses Epidemic Hospitalization ICU ICU admission ICU admissions intensive care Italian Italy Ministry of Health omicron Omicron variant Patient positive Prevalence prevalent retrieved SARS-CoV-2 severe acute respiratory syndrome Coronavirus Transmissibility variant variants Variants, Severity. widespread [DOI] 10.1016/j.ijid.2022.03.008 PMC 바로가기 [Article Type] Article
[Case-fatality rates of SARS-CoV-2 infection according to Autonomous Communities during the second epidemic wave in Spain]Observational Study Published on 2022-05-012022-10-04 Journal: Semergen [Category] COVID19(2023년), SARS, 임상, [키워드] age Analysis Asturias Balearic Island calculated Canary Islands carried Case-fatality rate cause Ceuta city Confidence intervals correlation Council COVID-19 Daily death Department Desigualdad en salud English epidemic wave estimate First wave group Health inequality health system Infection information Letalidad management material men Ministry of Health monitoring Mortality para Prevalence Public Rate Registered REL reported resources SARS-CoV-2 SARS-COV-2 infection Sex Significant significantly significantly higher Spain Spanish System transferred Valencian Weighting women [DOI] 10.1016/j.semerg.2022.02.004 PMC 바로가기 [Article Type] Observational Study